NEULAND LABORATORIES LTD. - 524558 - Outcome Of Board Meeting- Unaudited Standalone & Consolidated Financial Results Q3 And 9M FY 2020-21
Outcome of Board Meeting- Unaudited Standalone & Consolidated Financial Results Q3 and 9M FY 2020-2102-02-2021
02-02-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Meeting Updates
We refer to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 and enclose a copy of the Q3 FY 2020-2021 Earnings Call details, for your information and records.27-01-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith copies of the newspaper publication of Un-audited Financial Results for the quarter ended December 31, 2020, published in Financial Express and Andhra Prabha on January 8, 2021 for your reference. This is for your information and records.08-01-2021
NEULAND LABORATORIES LTD. - 524558 - Update on board meeting
The Board Meeting to be held on 03/02/2021 has been revised to 02/02/2021 We refer to our letter of even date and would like to inform you that we have inadvertently informed that the Board Meeting to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended December 31, 2020 is scheduled to be held on February 3, 2020. We request you to note that the Board Meeting to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended December 31, 2020 is scheduled to be held on Tuesday, February 2, 2021. We regret the inconvenience caused in this regard. This is for your information and records.07-01-2021
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended December 31, 2020
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2021 ,inter alia, to consider and approve the unaudited financial results for the quarter ended December 31, 202007-01-2021
NEULAND LABORATORIES LTD. - 524558 - Shareholding for the Period Ended December 31, 2020
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here06-01-2021
NEULAND LABORATORIES LTD. - 524558 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer06-01-2021
NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (Depositories and Participants) Regulations,201806-01-2021
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 of SEBI (LODR) Regulations, 201531-12-2020